Obesity and insulin resistance in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 27, Issue 5, 2011, Pages 300-306

  Chun Sen, Hsu ^a   Chien Hua, Wu ^b   Wan Chun, Chiu ^c   Ching Tzu, Lee ^a   Chun Jen, Chang ^a   Ming I, Hsu ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

insulin resistance; obesity; phenotypes; Polycystic ovary syndrome

Indexed keywords

FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

ACNE; ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BODY MASS INDEX; FASTING; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; OBESITY; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79953808748     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.488776     Document Type: Article

References (33)

1. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:302-312.
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev. 1997;18:774-800.
3. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
4. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-514. (Pubitemid 38072143)
5. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 2006;91:4842-4848. (Pubitemid 44917316)
6. Hsu MI, Liou TH, Chou SY, Chang CY, Hsu CS. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 2007;88:727-729.
7. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007;88:1389-1395. (Pubitemid 350030974)
8. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005;90:2571-2579. (Pubitemid 40686293)
9. Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol 2008;198:670.e1-e7; discussion 670.e7-e10.
10. Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 2009;92:1960-1965.
11. Hoeger K. Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001;28:85-97, vi-vii.
12. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004;109:2529-2535. (Pubitemid 38720552)
13. Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB, Jr, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The insulin resistance and atherosclerosis study. Diabetes 1996;45:1547-1555.
14. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: International Diabetes Institute; 2000.
15. The Rotterdam ESHRE/ASRM-sponsored PCOS workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
16. Hsu MI, Liou TH, Liang SJ, Su HW, Wu CH, Hsu CS. Inappropriate gonadotropin secretion in polycystic ovary syndrome. Fertil Steril 2009;91:1168-1174.
17. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004;82:661-665. (Pubitemid 39243189)
18. Kauffman RP, Baker VM, Dimarino P, Gimpel T, Castracane VD. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002;187:1362-1369. (Pubitemid 35397487)
19. Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod 2006;21:2027-2032. (Pubitemid 44288077)
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577. (Pubitemid 23118304)
21. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN; Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:48-53. (Pubitemid 43069116)
22. Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF. Obesity and the polycystic ovary syndrome. Minerva Endocrinol 2007;32:129-140.
23. Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:3626-3631. (Pubitemid 37034505)
24. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146. (Pubitemid 29028311)
25. Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004;61:738-746. (Pubitemid 40006795)
26. Ketel IJ, Stehouwer CD, Serné EH, et al. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 2008;93:3365-3372.
27. Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131-137. (Pubitemid 40898445)
28. Fulghesu AM, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti AM, Melis GB. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril 2006;86(2):398-404. (Pubitemid 44118963)
29. Chiu KC, Cohan P, Lee NP, Chuang LM. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 2000;23:1353-1358.
30. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223. (Pubitemid 9249478)
31. Angioni S, Portoghese E, Milano F, Melis GB, Fulghesu AM. Diagnosis of metabolic disorders in women with polycystic ovary syndrome. Obstet Gynecol Surv 2008;63(12):796-802.
32. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63. (Pubitemid 30022895)
33. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410. (Pubitemid 32269192)